Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass
Authors:
- Charles H. ChesnutCCCharles H. Chesnut
- David J. BaylinkDBDavid J. Baylink
- 31 March 1977
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 26 (3) , 267-277
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ANDROGEN-INDUCED HEPATOMAThe Lancet, 1975
- Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisJournal of Clinical Investigation, 1972
- Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosisThe American Journal of Medicine, 1972
- Effect of treatment of calcium kinetics in metabolic bone diseaseMetabolism, 1971
- In-Vivo neutron activation analysis of calcium in manThe International Journal of Applied Radiation and Isotopes, 1970
- Effect of sex hormones on bone in primary osteoporosisJournal of Clinical Investigation, 1969
- Estrogens and the aging process. The detection, prevention, and retardation of osteoporosisJAMA, 1966
- NEUTRON-ACTIVATION ANALYSIS IN MAN IN VIVOThe Lancet, 1964
- Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosisThe American Journal of Medicine, 1964
- THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSISJournal of Clinical Investigation, 1947